This review synthesizes rapid advances showing that programmable bacteria can target tumors, calm chronic inflammation, correct metabolic imbalances, and combat drug-resistant infections by acting as ...
CAMBRIDGE, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Sigilon Therapeutics, Inc. (SGTX), a biotechnology company that seeks to develop functional cures for acute and chronic diseases through its ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果